Hanson & Doremus Investment Management Abbott Laboratories Transaction History
Hanson & Doremus Investment Management
- $627 Million
- Q3 2024
A detailed history of Hanson & Doremus Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 11,165 shares of ABT stock, worth $1.28 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
11,165
Previous 11,165
-0.0%
Holding current value
$1.28 Million
Previous $1.16 Million
9.66%
% of portfolio
0.2%
Previous 0.19%
Shares
26 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.31BCall Options Held
8.74MPut Options Held
7.89M-
Vanguard Group Inc Valley Forge, PA168MShares$19.3 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.83 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.56 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.13 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $201B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...